Results 131 to 140 of about 8,545 (210)

Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database. [PDF]

Ther Adv Drug Saf
Xiong X, Chen Z, Yan B.
europepmc   +1 more source

Designing Novel Compound Candidates Against SARS-CoV-2 Using Generative Deep Neural Networks and Cheminformatics. [PDF]

Int J Mol Sci
Li SY, Hung CM, Hung HY, Lai CW, Lee MC.
europepmc   +1 more source

Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study. [PDF]

Nat Commun
Guo Z, Wei Y, Lin G, Jia KM, Boyer C, Wang H, Li C, Hung CT, Yam CHK, Chow TY, Zhao S, Li K, Yang A, Mok CKP, Hui DS, Yeoh EK, Chong KC.   +16 more
europepmc   +1 more source

On the ozonation of anti-SARS-CoV-2 substances and their nucleoside analogues for mechanistic understanding of the ozone induced transformation using HPLC-ESI-Q-TOF-HRMS. [PDF]

RSC Adv
Bartels I, Hoffmann-Jacobsen K, Schmidt TC, Jaeger M.   +3 more
europepmc   +1 more source

Inhibitory effects of molnupiravir on Crimean-Congo hemorrhagic fever virus polymerase. [PDF]

NAR Mol Med
Sloan A, Gordon CJ, Prévost J, Audet J, Fulton K, Woolner E, Chang MH, Walker SM, Tchesnokov EP, Das K, Safronetz D, Götte M.   +11 more
europepmc   +1 more source

DNA-dependent RNA polymerase incorporates β-D-N4-hydroxycytidine (NHC) linking Molnupiravir to host transcription-dependent mutagenesis. [PDF]

J Biol Chem
Garnier N, Xu H, Schinazi RF, Kim B.
europepmc   +1 more source

Tackling emerging viral diseases with epidemic potential [PDF]

, 2023
Li, Pengfei
core  

Repurposing of FDA-Approved Antiviral Drugs Against Monkeypox Virus: Comparative In Vitro Screening and Structure Based In Silico Studies. [PDF]

Pharmaceuticals (Basel)
Moatasim Y, Kutkat O, Gomaa M, Elshaier YAMM, Nabil M, El-Rashedy AA, Roshdy WH, Kayali G, Ali MA, El-Shesheny R.   +9 more
europepmc   +1 more source

An exploratory binding study of molnupiravir efficacy against emerging Omicron SARS-CoV-2 variants. [PDF]

Sci Rep
Ahmad F, Basharat Z, Janjua A, Najmi MH, Almajhdi FN, Hussain T, Ozsahin DU, Waheed Y.   +7 more
europepmc   +1 more source

Nucleoside analogue EIDD-1931 in the treatment of naturally occurring feline infectious peritonitis. [PDF]

J Feline Med Surg
Kennedy A, White J.
europepmc   +1 more source